Cargando…
Herpes Zoster, Hepatitis C, and Tuberculosis Risk with Apremilast Compared to Biologics, DMARDs and Corticosteroids to Treat Psoriasis and Psoriatic Arthritis
PURPOSE: Psoriasis and psoriatic arthritis (PsA) are associated with an increased infection risk. In this cohort study of patients with treated psoriasis or PsA, we used MarketScan (2014–2018) to estimate rates of herpes zoster, hepatitis C (HepC) and tuberculosis (TB) with apremilast compared to ot...
Autores principales: | Hagberg, Katrina Wilcox, Persson, Rebecca, Vasilakis-Scaramozza, Catherine, Niemcryk, Steve, Peng, Michael, Paris, Maria, Lindholm, Anders, Jick, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024766/ https://www.ncbi.nlm.nih.gov/pubmed/32104099 http://dx.doi.org/10.2147/CLEP.S239511 |
Ejemplares similares
-
Safety of Apremilast in Patients with Psoriasis and Psoriatic Arthritis: Findings from the UK Clinical Practice Research Datalink
por: Persson, Rebecca, et al.
Publicado: (2022) -
Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments
por: Persson, Rebecca, et al.
Publicado: (2022) -
Quality and Completeness of Myocardial Infarction Recording in Clinical Practice Research Datalink Aurum
por: Persson, Rebecca, et al.
Publicado: (2021) -
Rates of Cancers and Opportunistic Infections in Patients With Psoriatic Arthritis Compared With Patients Without Psoriatic Arthritis
por: Hagberg, Katrina Wilcox, et al.
Publicado: (2016) -
Apremilast monotherapy in DMARD-naive psoriatic arthritis patients: results of the randomized, placebo-controlled PALACE 4 trial
por: Wells, Alvin F, et al.
Publicado: (2018)